Pharma Mar | PHM - Current Liabilities


Pharma Mar reported EUR88.93M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Alaunos Therapeutics USD 921K 153K Sep/2025
Almirall EUR 298.52M 54.91M Jun/2025
Avita Medical AUD 62.6M 42.44M Jun/2025
Dianthus Therapeutics USD 23.86M 3.76M Sep/2025
Ionis Pharmaceuticals USD 903.46M 6.22M Sep/2025
IQVIA Holdings USD 8.51B 936M Sep/2025
Laboratorios Farma EUR 199.84M 121.75M Dec/2023
Moderna USD 1.68B 109M Sep/2025
Organon & Co USD 2.68B 117M Sep/2025
Pharma Mar EUR 88.93M 1.15M Sep/2025
Revvity USD 1.22B 550.93M Sep/2025
Tectonic Therapeutic USD 9.37M 1.99M Sep/2025
Viatris USD 7.36B 230.7M Sep/2025
Xeris Pharmaceuticals USD 116.2M 21.03M Sep/2025